Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis
Advanced Science · 2024
DOI: 10.1002/advs.202308235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Haoran Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Medical Innovation Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chine…. Hauptthemen laut MEDLINE: Cancer Vaccines, Extracellular Vesicles, Panax, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Medical Innovation Center, Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine, Fundamental Research Funds of Nanjing Universities of Chinese Medicine.
Abstract (Originalsprache)
Personalized cancer vaccines based on resected tumors from patients is promising to address tumor heterogeneity to inhibit tumor recurrence or metastasis. However, it remains challenge to elicit immune activation due to the weak immunogenicity of autologous tumor antigens. Here, a hybrid membrane cancer vaccine is successfully constructed by membrane fusion to enhance adaptive immune response and amplify personalized immunotherapy, which formed a codelivery system for autologous tumor antigens and immune adjuvants. Briefly, the functional hybrid vesicles (HM‐NPs) are formed by hybridizing ginseng‐derived extracellular vesicles‐like particles (G‐EVLPs) with the membrane originated from the resected autologous tumors. The introduction of G‐EVLPs can enhance the phagocytosis of autologous tumor antigens by dendritic cells (DCs) and facilitate DCs maturation through TLR4, ultimately activating tumor‐specific cytotoxic T lymphocytes (CTLs). HM‐NPs can indeed strengthen specific immune responses to suppress tumors recurrence and metastasis including subcutaneous tumors and orthotopic tumors. Furthermore, a long‐term immune protection can be obtained after vaccinating with HM‐NPs, and prolonging the survival of animals. Overall, this personalized hybrid autologous tumor vaccine based on G‐EVLPs provides the possibility of mitigating tumor recurrence and metastasis after surgery while maintaining good biocompatibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Provincial Medical Innovation Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
- Chinatalentgroup (CTG Group), Beijing, 100020, China.
ORCID-Profile: Haoran Wang
Förderung
- Jiangsu Provincial Medical Innovation Center
- Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine
- Fundamental Research Funds of Nanjing Universities of Chinese Medicine
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Jiangsu Provincial Key Research and Development Program
- Key Technologies Research and Development Program
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
Zitieren
APA
Wang, H., Mu, J., Chen, Y., Liu, Y., Li, X., Li, H., & Cao, P. (2024). Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis. Advanced Science. https://doi.org/10.1002/advs.202308235
Vancouver
Wang H, Mu J, Chen Y, Liu Y, Li X, Li H, et al. Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis. Advanced Science. 2024. doi:10.1002/advs.202308235
BibTeX
@article{Wang2024,
author = {Wang, Haoran and Mu, Jiankang and Chen, Yexing and Liu, Yali and Li, Xianghui and Li, Hao and Cao, Peng},
title = {Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202308235}
}
EUVIMED